Venture Capital Archives - Page 78 of 111 - Boston Life Sciences Times

Casma Therapeutics Secures $7.6 Million in MJFF Funding to Advance Parkinson’s Disease Program

March 10, 2026

NEJM Publishes Data Suggesting Zorevunersen May Modify Disease Course in Dravet Syndrome

March 5, 2026

Arsenal Medical Treats First Patient with ResQFoam Device for Life-Threatening Abdominal Bleeding

March 4, 2026

THIS WEEK'S STORIES

UK Biotech Firm Abselion Opens U.S. Subsidiary in Cambridge Innovation Hub

March 9, 2026

WHOOP Expands Health Platform with Women’s Blood Biomarker Panel and New Cycle Insights Tools

March 10, 2026

Qlaris Bio Appoints Fred Guerard, Pharm.D., as President and Chief Executive Officer

March 10, 2026

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Venture Capital

Cambridge Startup Axiomatic AI Raises $18M to Build Verified AI Platform for Engineering

Cognito Therapeutics Raises $105 Million Series C to Advance Alzheimer’s Therapy Platform

Poplar Therapeutics Raises $45 Million to Advance Anti-IgE Therapy for Food Allergy and Atopic Diseases

BreezeBio Raises $60 Million in Series B to Advance Precision Genetic Medicines Pipeline

Synthpop Raises $15 Million Series A to Expand AI Platform for Healthcare Workflow Automation

Most Read

ZoomRx Study Finds Routine Pediatric Vaccine Visits May Be Changing After Federal Guidance Shift

Carna Health Expands Global Chronic Kidney Disease Screening Programs on World Kidney Day

Pretzel Therapeutics Presents Preclinical Data Supporting PX578 Development for POLG Disease

Insulet Reports Promising Study Results for Fully Closed-Loop Automated Insulin Delivery System for Adults with Type 2 Diabetes

EDITOR PICKS

Casma Therapeutics Secures $7.6 Million in MJFF Funding to Advance Parkinson’s Disease Program

NEJM Publishes Data Suggesting Zorevunersen May Modify Disease Course in Dravet Syndrome

Arsenal Medical Treats First Patient with ResQFoam Device for Life-Threatening Abdominal Bleeding

THIS WEEK'S STORIES

UK Biotech Firm Abselion Opens U.S. Subsidiary in Cambridge Innovation Hub

WHOOP Expands Health Platform with Women’s Blood Biomarker Panel and New Cycle Insights Tools

Qlaris Bio Appoints Fred Guerard, Pharm.D., as President and Chief Executive Officer

POPULAR CATEGORY

ABOUT US

FOLLOW US